Target intelligence / Profile preview

SPRY domain-containing SOCS box protein 4 (SPSB4)

Target
SPSB4
Molecular classification
E3 ubiquitin ligase (SOCS box protein family), SPRY domain-containing protein, Adapter protein (Elongin BC ligase complex component)
01

Overview

SPSB4 (SPRY domain-containing SOCS box protein 4) is an adaptor protein that forms part of a Cullin5-based E3 ubiquitin ligase complex, characterized by a central SPRY domain for substrate recognition and a C-terminal SOCS box domain for ubiquitin ligase assembly[1][2][7][8]. SPSB4 targets proteins, including NOS2, NR1D1, and EphB2, for ubiquitination and subsequent proteasomal degradation, thereby regulating nitric oxide production in macrophages, circadian transcriptional repressors, and EphB2-dependent cell signaling[4][7][8][9]. Dysregulation or mutation of SPSB4 is implicated in pathways relevant to inflammation, cancer (e.g., affecting apoptosis regulators like Par-4), and other diseases[1][7][9]. SPSB4 is a validated molecular target for modulating ubiquitin-proteasome degradation in selected cellular processes.

Other names
SplA/ryanodine receptor domain and SOCS box containing 4SPSB4SSB4SSB-4SPRY domain-containing SOCS box protein SSB-4
02

Mechanism of action

Ubiquitination and proteasomal degradation of substrate proteins, such as NOS2 (inducible nitric oxide synthase), NR1D1 (nuclear receptor involved in circadian rhythm), and EphB2 (receptor tyrosine kinase)

03

Biological functions

Protein ubiquitinationUbiquitin-dependent proteasomal degradationSignal transduction regulationRegulation of nitric oxide (NO) production in macrophagesRegulation of circadian protein stability
04

Disease associations

Cancer (e.g., alters apoptosis pathways and interacts with proteins involved in tumor formation)Inflammation (modulates macrophage NO response)Other (implicated in kidney disease e.g., Branchiootorenal Syndrome 1, and childhood kidney cell carcinoma)
05

Safety considerations

Potential off-target effects on unrelated substrate proteins due to ubiquitin ligase activityUnintended modulation of apoptosis, immune function, or circadian rhythm if targeted pharmacologically

Beyond the preview

Go deeper on SPRY domain-containing SOCS box protein 4 (SPSB4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPRY domain-containing SOCS box protein 4 (SPSB4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call